Gregory Mark Enns MD
Clinical Biochemical Genetics, Clinical Genetics
Associate Professor, Pediatrics - Medical Genetics, Stanford University Medical Center
Join to View Full Profile
725 Welch RdPalo Alto, CA 94304
Phone+1 650-497-8000
Dr. Enns is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Residency, Medical Genetics and Genomics, 1995 - 1998
Children's Hospital Los AngelesResidency, Pediatrics, 1991 - 1995
University of Glasgow Faculty of MedicineClass of 1990
Certifications & Licensure
OR State Medical License 2011 - Present
HI State Medical License 2003 - 2028
CA State Medical License 1993 - 2027
FL State Medical License 2012 - 2020
American Board of Medical Genetics and Genomics Clinical Biochemical Genetics- American Board of Medical Genetics and Genomics Clinical Genetics and Genomics
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- EPI-743 for Mitochondrial Respiratory Chain Diseases
- Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic Acidemia Start of enrollment: 2012 Sep 01
- Short-Term Outcome of N-Carbamylglutamate in the Treatment of Acute Hyperammonemia Start of enrollment: 2012 Sep 01
Publications & Presentations
PubMed
- 1 citationsClinical Characteristics of Arginase 1 Deficiency: Natural History Insights From International Clinical Trials.Mattias Rudebeck, Nancy Braverman, Richard Chang, Gregory M Enns, Arunabha Ghosh
Journal of Inherited Metabolic Disease. 2026-03-01 - 1 citationsLong-Term Efficacy and Tolerability of Pegzilarginase in Arginase 1 Deficiency: Results of Two International Multicentre Open-Label Extension Studies.Markey McNutt, Frank Rutsch, Rossana Sanchez Russo, Serena Gasperini, Spyros Batzios
Journal of Inherited Metabolic Disease. 2025-07-01 - Corrigendum to "Genetic Analysis and multimodal imaging confirm m.12148 T>C mitochondrial variant pathogenicity leading to multisystem dysfunction" [Molecular Genetics...Kinsley Belle, Alexander Kreymerman, Jill L Young, Nirmal Vadgama, Marco H Ji
Molecular Genetics and Metabolism. 2025-05-01
Press Mentions
M6P Therapeutics to Host Key Opinion Leader Webinar on Lysosomal Storage DisordersJuly 19th, 2021- M6P Therapeutics Announces Formation of Distinguished, Experienced Scientific Advisory BoardFebruary 3rd, 2021
The Bay Area's Top Doctors of 2019January 17th, 2019
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
